The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses

Trends in Endocrinology and Metabolism

Volumn 21, Issue 5, 2010, Pages 325-334

  Assié, Guillaume ^a   Guillaud Bataille, Marine ^a   Ragazzon, Bruno ^a   Bertagna, Xavier ^a   Bertherat, Jérôme ^a   Clauser, Eric ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENODOXIN; ALDOSTERONE SYNTHASE; ANDROGEN; ANGIOTENSIN II; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CHROMOGRANIN A; CORTICOTROPIN; CYCLIN DEPENDENT KINASE 6; G PROTEIN COUPLED RECEPTOR; HYDROCORTISONE; LUTEINIZING HORMONE; MELAN A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STEROID 17ALPHA MONOOXYGENASE; SYNAPTOPHYSIN; TRANSCRIPTOME;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ANDROGEN SYNTHESIS; CARCINOGENESIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HYDROCORTISONE RELEASE; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSCRIPTOMICS; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

ADENOMA; ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ANIMALS; CARCINOMA; GENE EXPRESSION PROFILING; HUMANS; HYPERALDOSTERONISM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 77952510754     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2009.12.009     Document Type: Review

References (39)

1. Whitfield M.L., et al. Common markers of proliferation. Nat. Rev. Cancer 2006, 6:99-106.
2. Cheang M.C., et al. Gene expression profiling of breast cancer. Annu. Rev. Pathol. 2008, 3:67-97.
3. Hu R.M., et al. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9543-9548.
4. Assie G., et al. Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. J. Clin. Endocrinol. Metab. 2005, 90:6638-6649.
5. Horvath A., et al. Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. J. Clin. Endocrinol. Metab. 2006, 91:584-596.
6. Rebouissou S., et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009, 457:200-204.
7. Velculescu V.E., et al. Serial analysis of gene expression. Science 1995, 270:484-487.
8. Bender R.A., Erlander M.G. Molecular classification of unknown primary cancer. Semin. Oncol. 2009, 36:38-43.
9. Lau S.K., Weiss L.M. The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum. Pathol. 2009, 40:757-768.
10. Ribeiro R.C., Figueiredo B. Childhood adrenocortical tumours. Eur. J. Cancer 2004, 40:1117-1126.
11. Zhang H., et al. Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors. Appl. Immunohistochem. Mol. Morphol. 2008, 16:32-39.
12. Clark B.J., Stocco D.M. Steroidogenic acute regulatory protein: the StAR still shines brightly. Mol. Cell. Endocrinol. 1997, 134:1-8.
13. Bassett M.H., et al. The regulation of aldosterone synthase expression. Mol. Cell. Endocrinol. 2004, 217:67-74.
14. Miller W.L. Steroidogenic enzymes. Endocr. Dev. 2008, 13:1-18.
15. Barlaskar F.M., et al. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2009, 94:204-212.
16. Bassett M.H., et al. Expression profiles for steroidogenic enzymes in adrenocortical disease. J. Clin. Endocrinol. Metab. 2005, 90:5446-5455.
17. Lenzini L., et al. Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 2007, 50:1106-1113.
18. Honda T., et al. Combined primary aldosteronism and preclinical Cushing's syndrome: an unusual case presentation of adrenal adenoma. Hypertens. Res. 2001, 24:723-726.
19. Enberg U., et al. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur. J. Endocrinol. 2004, 151:73-85.
20. Saner-Amigh K., et al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 2006, 91:1136-1142.
21. Ye P., et al. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J. Endocrinol. 2007, 195:39-48.
22. Bourdeau I., et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 2004, 23:1575-1585.
23. Lampron A., et al. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. J. Clin. Endocrinol. Metab. 2006, 91:3611-3618.
24. de Fraipont F., et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J. Clin. Endocrinol. Metab. 2005, 90:1819-1829.
25. de Reynies A., et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 2009, 27:1108-1115.
26. Giordano T.J., et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003, 162:521-531.
27. Costa M.H., Lacroix A. Cushing's syndrome secondary to ACTH-independent macronodular adrenal hyperplasia. Arq. Bras. Endocrinol. Metabol. 2007, 51:1226-1237.
28. Lee S., et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin. Endocrinol. (Oxf.) 2005, 63:625-630.
29. Vezzosi D., et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur. J. Endocrinol. 2007, 156:21-31.
30. Libe R., Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur. J. Endocrinol. 2005, 153:477-487.
31. Wang W., et al. Differentially expressed genes in zona reticularis cells of the human adrenal cortex. Mol. Cell. Endocrinol. 2001, 173:127-134.
32. Rainey W.E., et al. Gene profiling of human fetal and adult adrenals. J. Endocrinol. 2001, 171:209-215.
33. Velazquez-Fernandez D., et al. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 2005, 138:1087-1094.
34. Laurell C., et al. Transcriptional profiling enables molecular classification of adrenocortical tumours. Eur. J. Endocrinol. 2009, 161:141-152.
35. Almeida M.Q., et al. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J. Clin. Endocrinol. Metab. 2008, 93:3524-3531.
36. Slater E.P., et al. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur. J. Endocrinol. 2006, 154:587-598.
37. Giordano T.J., et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 2009, 15:668-676.
38. Michalkiewicz E., et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J. Clin. Oncol. 2004, 22:838-845.
39. West A.N., et al. Gene expression profiling of childhood adrenocortical tumors. Cancer Res. 2007, 67:600-608.